BEAMSTART Logo

Atropos Health Secures $30 Million in Funding from McKesson and Merck to Advance Drug Development through Artificial Intelligence

VentureBeat LogoVentureBeat3w ago

 Atropos Health Secures $30 Million in Funding from McKesson and Merck to Advance Drug Development through Artificial Intelligence - VentureBeat

Quick Summary:

Atropos Health raises $30 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development.


More Pictures

 Atropos Health Secures $30 Million in Funding from McKesson and Merck to Advance Drug Development through Artificial Intelligence - VentureBeat (Picture 1)

or

Article Details

Author / Journalist: Michael Nuñez

Category: StartupsTechnology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-05-23 @ 22:08:10 (3 weeks ago)

News Timezone: GMT -5:00

News Source URL: venturebeat.com

Language: English

Article Length: 26 words

Reading Time: 1 minutes read

Sentences: 28 lines

Sentence Length: 1 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © VentureBeat

News ID: 21069841

View Article Analysis

About VentureBeat

Main Topics: StartupsTechnology

Official Website: venturebeat.com

Update Frequency: 1 posts per day

Year Established: 2005

Headquarters: United States

News Last Updated: 20 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #50

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story " Atropos Health Secures $30 Million in Funding from McKesson and Merck to Advance Drug Development through Artificial Intelligence" has 26 words across 28 sentences, which will take approximately 1 minutes for the average person to read.

Which news outlet covered this story?

The story " Atropos Health Secures $30 Million in Funding from McKesson and Merck to Advance Drug Development through Artificial Intelligence" was covered 3 weeks ago by VentureBeat, a news publisher based in United States.

How trustworthy is 'VentureBeat' news outlet?

VentureBeat is a fully independent (privately-owned) news outlet established in 2005 that covers mostly startups and technology news.

The outlet is headquartered in United States and publishes an average of 1 news stories per day.

It's most recent story was published 20 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #21069841
  • URL: https://beamstart.com/news/mckesson-merck-back-atropos-healths-17165029782352

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.